Accès gratuit
Med Sci (Paris)
Volume 17, Numéro 11, Novembre 2001
Page(s) 1112 - 1119
Section Articles de Synthèse
Publié en ligne 15 novembre 2001
  1. Salfinger M. Characteristics of the various species of Mycobacteria. In : Rom WN, Garay SM, eds. Tuberculosis. New York : Little Brown and Company Inc, 1996 : 161–70.
  2. Wolinsky E. Mycobacteria. In : Davis BD, Dulbecco R, Eisen HN, Ginsberg HS, eds. Microbiology, 4th ed. Philadelphia : J.B. Lippincott Company, 1990 : 647–64.
  3. Calmette A.La vaccination préventive contre la tuberculose par le BCG. Paris : Masson, 1927.
  4. Holland SM. Nontuberculous mycobacteria. Am J Med Sci 2001; 321 : 49–55.
  5. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19 : 93–129.
  6. Stenger S, Modlin RL. T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol 1999; 2 : 89–93.
  7. Kobayashi K, Yoshida T. The immunopathogenesis of granulomatous inflammation induced by Mycobacterium tuberculosis. Meth Enzymol 1996; 9 : 204–14.
  8. Drobniewski F, Pozniak A, Uttley A. Tuberculosis and AIDS. J Med Microbiol 1995; 43 : 85–91.
  9. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol 1999; 118 (suppl 1) : 1–28.
  10. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection.Lancet 1995; 346 : 581.
  11. Casanova L, Blanche S, Emile JF, et al. Idiopathic disseminated bacillus Calmette-Guerin infection : a French national retrospective study. Pediatrics 1996; 98 : 774–8.
  12. Bach EA, Aguet M, Schreiber RD. The IFN gamma receptor : a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997; 15 : 563–91.
  13. Altare F, Jouanguy E, Lamhamedi-Cherradi S, et al. A causative relationship between mutant IFNγR1 alleles and impaired cellular response to IFN gamma in a compound heterozygous child. Am J Hum Genet 1998; 62 : 723–6.
  14. Holland SA, Dorman SE, Kwon A, et al . Abnormal regulation of interferon gamma, interleukin 12, and tumor necrosis factor alpha in interferon gamma receptor 1 deficiency. J Infect Dis 1998; 178 : 1095–104.
  15. Jouanguy E, Altare F, Lamhamedi S,et al .Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 1996; 335 : 1956–61.
  16. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335 : 1941–9.
  17. Pierre-Audigier C, Jouanguy E, Lamhamedi S, et al. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis 1997; 24 : 982–4.
  18. Roesler J, Kofink B, Wendisch J, et al. Recurrent mycobacterial and Listeria infections in a child with interferon γ receptor deficiency. Exp Hematol 1999; 27 : 1368–74.
  19. Jouanguy E, Dupuis S, Pallier A, et al. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma, J Clin Invest 2000; 105 : 1429–36.
  20. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998; 101 : 2364–9.
  21. Fieschi C, Dupuis S, Picard,C, Smith CI, Holland SM, Casanova JL. High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics 2001; 107 : E48.
  22. Jouanguy E, Lamhamedi-Cherradi S, Altare F, et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 1997; 100 : 2658–64.
  23. Allende LM, Lopez-Goyanes A, Paz-Artal E, et al. A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency. Clin Diagn Lab Immunol 2001; 8 : 133–7.
  24. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999; 21 : 370–8.
  25. Villella A, Picard C, Jouanguy E, et al. Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics 2001; 107 : E47.
  26. Doffinger R, Jouanguy E, Dupuis S, et al. Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection. J Infect Dis 2000; 181 : 379–84.
  27. Dupuis S, Dargemont C, Thomassin N, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001; 293 : 300–3.
  28. Dupuis S, Doffinger R, Picard C, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000; 178 : 129–37.
  29. Remus N, Reichenbach J, Picard C, et al. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res 2001; 50 : 8–13.
  30. Trinchieri G. Interleukin-12 : a cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70 : 83–243.
  31. Presky DH, Yang H, Minetti LJ, et al. A functional interleukin 12 receptor complex is composed of two beta- type cytokine receptor subunits. Proc Natl Acad Sci USA 1996; 93 : 14002–7.
  32. Zou J, Presky DH, Wu CY, Gubler U. Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta-1 and beta-2 and JAK kinases. J Biol Chem 1997; 272 : 6073–7.
  33. Jacobson NG, Szabo SJ, Weber-Nordt RM, et al. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 1995; 181 : 1755–62.
  34. Naeger LK, McKinney J, Salvekar A, Hoey,T. Identification of a STAT4 binding site in the interleukin-12 receptor required for signaling. J Biol Chem 1999; 274 : 1875–8.
  35. Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Buschenfelde KH, Neurath MF. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol 1998; 160 : 3642–7.
  36. Altare F, Lammas D, Revy P, et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin infection. J Clin Invest 1998; 102 : 2035–40.
  37. Aksu G, Trpan C, Çavuolu C, Soydan S, Altare F, Casanova JL, Kutukculer N. Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta-1 deficiency. Pediatr Infect Dis J 2001; 20 : 551–3.
  38. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280 : 1432–5.
  39. De Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998; 280: 1435–8.
  40. Sakai T, Matsuoka M, Aoki M, Nosaka K, Mitsuya H. Missense mutation of the interleukin-12 receptor beta-1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. Blood 2001; 97 : 2688–94.
  41. Altare F, Ensser A, Breiman A, et al. Interleukin-12 receptor β1-deficiency in a patient with abdominal tuberculosis. J Infect Dis 2001; 184 : 231–6.
  42. Altare F, Jouanguy E, Lamhamedi S, Döffinger R, Fischer A, Casanova JL. Mendelian susceptibility to mycobacterial infections in man. Curr Opin Immunol 1998; 10 : 413–7.
  43. Horvath KD, Whelan RL. Intestinal tuberculosis : return of an old disease. Am J Gastroenterol 1998; 93 : 692–6.
  44. Verhagen CE, de Boer T, Smits HH, et al. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta-1 (IL-12R beta-1). Evidence for an IL-12R beta-1-independent pathway of IL-12 responsiveness in human T cells. J Exp Med 2000; 192 : 517–28.
  45. Zhang M, Gately MK, Wang E, et al. Interleukin 12 at the site of disease in tuberculosis, J Clin Invest 1994; 93 : 1733–9.
  46. Zhang M, Gong J, Presky DH, Xue W, Barnes PF. Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J Immunol 1999; 162 : 2441–7.
  47. Flesch IE, Hess JH, Huang S, et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med 1995; 181 : 1615–21.
  48. DiTirro J, Rhoades ER, Roberts AD, et al. Disruption of the cellular inflammatory response to Listeria monocytogenes infection in mice with disruptions in targeted genes. Infect Immun 1998; 66 : 2284–9.
  49. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M. Consensus statement. Global burden of tuberculosis : estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282 : 677–86.
  50. Abel L, Casanova JL, Genetic predisposition to clinical tuberculosis : bridging the gap between simple and complex inheritance. Am J Hum Genet 2000; 67 : 274–7.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.